Specialty Generics Market Set for Robust Growth with an 8.7% CAGR Through 2032
The global Specialty Generics Market is projected to experience significant growth, with its size expected to rise from USD 74.3 billion in 2022 to approximately USD 167.6 billion by 2032, representing a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2023 to 2032. This growth is driven by several key factors, including the increasing demand for cost-effective healthcare solutions, the expiration of patents for high-cost brand-name specialty drugs, and the evolving healthcare policies favoring generic drug use. The specialty generics sector primarily includes generic versions of biologic-based drugs used to treat complex chronic conditions such as…
- Date: May 24, 2024
- Author: Robert Shaw
- Category: PharmiWeb